Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
MALVERN, Pa., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or…
Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting
December 03, 2024 16:05 ET | Source: Bionomics Ltd ADELAIDE, Australia and…
Bharath Advanced Therapeutics (BAT) and FABA Present Cancer NEXT 2024: Pioneering Innovation in Cancer Research
HYDERABAD, India, Nov. 29, 2024 /PRNewswire/ -- Bharath Advanced Therapeutics (BAT) and…
Bharath Advanced Therapeutics (BAT) and FABA Present Cancer NEXT 2024: Pioneering Innovation in Cancer Research
HYDERABAD, India, Nov. 29, 2024 /PRNewswire/ -- Bharath Advanced Therapeutics (BAT) and…
Bharath Advanced Therapeutics (BAT) and FABA Present Cancer NEXT 2024: Pioneering Innovation in Cancer Research
HYDERABAD, India, Nov. 29, 2024 /PRNewswire/ -- Bharath Advanced Therapeutics (BAT) and…
Bharath Advanced Therapeutics (BAT) and FABA Present Cancer NEXT 2024: Pioneering Innovation in Cancer Research
HYDERABAD, India, Nov. 29, 2024 /PRNewswire/ -- Bharath Advanced Therapeutics (BAT) and…